A neurotransmitter. Acetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. It is generally not used as an administered drug because it is broken down very rapidly by cholinesterases, but it is useful in some ophthalmological applications.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Esmolol | The risk or severity of adverse effects can be increased when Esmolol is combined with Acetylcholine. |
| Betaxolol | The risk or severity of adverse effects can be increased when Betaxolol is combined with Acetylcholine. |
| Metoprolol | The risk or severity of adverse effects can be increased when Metoprolol is combined with Acetylcholine. |
| Atenolol | The risk or severity of adverse effects can be increased when Atenolol is combined with Acetylcholine. |
| Timolol | The risk or severity of adverse effects can be increased when Timolol is combined with Acetylcholine. |
| Sotalol | The risk or severity of adverse effects can be increased when Sotalol is combined with Acetylcholine. |
| Propranolol | The risk or severity of adverse effects can be increased when Propranolol is combined with Acetylcholine. |
| Labetalol | The risk or severity of adverse effects can be increased when Labetalol is combined with Acetylcholine. |
| Bisoprolol | The risk or severity of adverse effects can be increased when Bisoprolol is combined with Acetylcholine. |
| Alprenolol | The risk or severity of adverse effects can be increased when Alprenolol is combined with Acetylcholine. |
| Pindolol | The risk or severity of adverse effects can be increased when Pindolol is combined with Acetylcholine. |
| Carvedilol | The risk or severity of adverse effects can be increased when Carvedilol is combined with Acetylcholine. |
| Propafenone | The risk or severity of adverse effects can be increased when Propafenone is combined with Acetylcholine. |
| Acebutolol | The risk or severity of adverse effects can be increased when Acebutolol is combined with Acetylcholine. |
| Nadolol | The risk or severity of adverse effects can be increased when Nadolol is combined with Acetylcholine. |
| Bevantolol | The risk or severity of adverse effects can be increased when Bevantolol is combined with Acetylcholine. |
| Practolol | The risk or severity of adverse effects can be increased when Practolol is combined with Acetylcholine. |
| Penbutolol | The risk or severity of adverse effects can be increased when Penbutolol is combined with Acetylcholine. |
| Oxprenolol | The risk or severity of adverse effects can be increased when Oxprenolol is combined with Acetylcholine. |
| Dexpropranolol | The risk or severity of adverse effects can be increased when Dexpropranolol is combined with Acetylcholine. |
| Celiprolol | The risk or severity of adverse effects can be increased when Celiprolol is combined with Acetylcholine. |
| Nebivolol | The risk or severity of adverse effects can be increased when Nebivolol is combined with Acetylcholine. |
| Bufuralol | The risk or severity of adverse effects can be increased when Bufuralol is combined with Acetylcholine. |
| Bopindolol | The risk or severity of adverse effects can be increased when Bopindolol is combined with Acetylcholine. |
| Bupranolol | The risk or severity of adverse effects can be increased when Bupranolol is combined with Acetylcholine. |
| Indenolol | The risk or severity of adverse effects can be increased when Indenolol is combined with Acetylcholine. |
| Arotinolol | The risk or severity of adverse effects can be increased when Arotinolol is combined with Acetylcholine. |
| Levobetaxolol | The risk or severity of adverse effects can be increased when Levobetaxolol is combined with Acetylcholine. |
| Talinolol | The risk or severity of adverse effects can be increased when Talinolol is combined with Acetylcholine. |
| Anisodamine | The risk or severity of adverse effects can be increased when Anisodamine is combined with Acetylcholine. |
| Bucindolol | The risk or severity of adverse effects can be increased when Bucindolol is combined with Acetylcholine. |
| Esatenolol | The risk or severity of adverse effects can be increased when Esatenolol is combined with Acetylcholine. |
| Cloranolol | The risk or severity of adverse effects can be increased when Cloranolol is combined with Acetylcholine. |
| Mepindolol | The risk or severity of adverse effects can be increased when Mepindolol is combined with Acetylcholine. |
| Epanolol | The risk or severity of adverse effects can be increased when Epanolol is combined with Acetylcholine. |
| Tertatolol | The risk or severity of adverse effects can be increased when Tertatolol is combined with Acetylcholine. |
| Landiolol | The risk or severity of adverse effects can be increased when Landiolol is combined with Acetylcholine. |
| Cimetropium | Acetylcholine may decrease the anticholinergic activities of Cimetropium. |
| Pegvisomant | The risk or severity of adverse effects can be increased when Pegvisomant is combined with Acetylcholine. |
| Mefloquine | The risk or severity of adverse effects can be increased when Mefloquine is combined with Acetylcholine. |
| Tacrine | The risk or severity of adverse effects can be increased when Tacrine is combined with Acetylcholine. |
| Sulpiride | The risk or severity of adverse effects can be increased when Sulpiride is combined with Acetylcholine. |
| Profenamine | The risk or severity of adverse effects can be increased when Profenamine is combined with Acetylcholine. |
| Chlorpromazine | The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Acetylcholine. |
| Gallamine triethiodide | The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Acetylcholine. |
| Triflupromazine | The risk or severity of adverse effects can be increased when Triflupromazine is combined with Acetylcholine. |
| Cisplatin | The risk or severity of adverse effects can be increased when Cisplatin is combined with Acetylcholine. |
| Cinchocaine | The risk or severity of adverse effects can be increased when Cinchocaine is combined with Acetylcholine. |
| Pyridostigmine | The risk or severity of adverse effects can be increased when Pyridostigmine is combined with Acetylcholine. |
| Nizatidine | The risk or severity of adverse effects can be increased when Nizatidine is combined with Acetylcholine. |
| Galantamine | The risk or severity of adverse effects can be increased when Galantamine is combined with Acetylcholine. |
| Isoflurophate | The risk or severity of adverse effects can be increased when Isoflurophate is combined with Acetylcholine. |
| Diethylcarbamazine | The risk or severity of adverse effects can be increased when Diethylcarbamazine is combined with Acetylcholine. |
| Procaine | The risk or severity of adverse effects can be increased when Procaine is combined with Acetylcholine. |
| Minaprine | The risk or severity of adverse effects can be increased when Minaprine is combined with Acetylcholine. |
| Terbutaline | The risk or severity of adverse effects can be increased when Terbutaline is combined with Acetylcholine. |
| Mechlorethamine | The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Acetylcholine. |
| Hexafluronium | The risk or severity of adverse effects can be increased when Hexafluronium is combined with Acetylcholine. |
| Demecarium | The risk or severity of adverse effects can be increased when Demecarium is combined with Acetylcholine. |
| Physostigmine | The risk or severity of adverse effects can be increased when Physostigmine is combined with Acetylcholine. |
| Rivastigmine | The risk or severity of adverse effects can be increased when Rivastigmine is combined with Acetylcholine. |
| Edrophonium | The risk or severity of adverse effects can be increased when Edrophonium is combined with Acetylcholine. |
| Memantine | The risk or severity of adverse effects can be increased when Memantine is combined with Acetylcholine. |
| Ambenonium | The risk or severity of adverse effects can be increased when Ambenonium is combined with Acetylcholine. |
| Tubocurarine | The risk or severity of adverse effects can be increased when Tubocurarine is combined with Acetylcholine. |
| Ketamine | The risk or severity of adverse effects can be increased when Ketamine is combined with Acetylcholine. |
| Metoclopramide | The risk or severity of adverse effects can be increased when Metoclopramide is combined with Acetylcholine. |
| Decamethonium | The risk or severity of adverse effects can be increased when Decamethonium is combined with Acetylcholine. |
| Pipecuronium | The risk or severity of adverse effects can be increased when Pipecuronium is combined with Acetylcholine. |
| Ginkgo biloba | The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Acetylcholine. |
| Neostigmine | The risk or severity of adverse effects can be increased when Neostigmine is combined with Acetylcholine. |
| Bambuterol | The risk or severity of adverse effects can be increased when Bambuterol is combined with Acetylcholine. |
| 1,10-Phenanthroline | The risk or severity of adverse effects can be increased when 1,10-Phenanthroline is combined with Acetylcholine. |
| Thiotepa | The risk or severity of adverse effects can be increased when Thiotepa is combined with Acetylcholine. |
| Huperzine A | The risk or severity of adverse effects can be increased when Huperzine A is combined with Acetylcholine. |
| Phenserine | The risk or severity of adverse effects can be increased when Phenserine is combined with Acetylcholine. |
| Regramostim | The risk or severity of adverse effects can be increased when Regramostim is combined with Acetylcholine. |
| Aprotinin | The risk or severity of adverse effects can be increased when Aprotinin is combined with Acetylcholine. |
| Betaine | The risk or severity of adverse effects can be increased when Betaine is combined with Acetylcholine. |
| Capsaicin | The risk or severity of adverse effects can be increased when Capsaicin is combined with Acetylcholine. |
| Coumaphos | The risk or severity of adverse effects can be increased when Coumaphos is combined with Acetylcholine. |
| Dichlorvos | The risk or severity of adverse effects can be increased when Dichlorvos is combined with Acetylcholine. |
| Fenthion | The risk or severity of adverse effects can be increased when Fenthion is combined with Acetylcholine. |
| Metrifonate | The risk or severity of adverse effects can be increased when Metrifonate is combined with Acetylcholine. |
| Acotiamide | The risk or severity of adverse effects can be increased when Acotiamide is combined with Acetylcholine. |
| Methanesulfonyl Fluoride | The risk or severity of adverse effects can be increased when Methanesulfonyl Fluoride is combined with Acetylcholine. |
| Paraoxon | The risk or severity of adverse effects can be increased when Paraoxon is combined with Acetylcholine. |
| Tyrothricin | The risk or severity of adverse effects can be increased when Tyrothricin is combined with Acetylcholine. |
| Ipidacrine | The risk or severity of adverse effects can be increased when Ipidacrine is combined with Acetylcholine. |
| Distigmine | The risk or severity of adverse effects can be increased when Distigmine is combined with Acetylcholine. |
| Tretamine | The risk or severity of adverse effects can be increased when Tretamine is combined with Acetylcholine. |
| Posiphen | The risk or severity of adverse effects can be increased when Posiphen is combined with Acetylcholine. |
| Methylphosphinic Acid | The risk or severity of adverse effects can be increased when Methylphosphinic Acid is combined with Acetylcholine. |
| Patent Blue | The therapeutic efficacy of Acetylcholine can be decreased when used in combination with Patent Blue. |
| Capreomycin | The therapeutic efficacy of Acetylcholine can be decreased when used in combination with Capreomycin. |
| Framycetin | The therapeutic efficacy of Acetylcholine can be decreased when used in combination with Framycetin. |
| Amikacin | The therapeutic efficacy of Acetylcholine can be decreased when used in combination with Amikacin. |
| Tobramycin | The therapeutic efficacy of Acetylcholine can be decreased when used in combination with Tobramycin. |
| Gentamicin | The therapeutic efficacy of Acetylcholine can be decreased when used in combination with Gentamicin. |
| Netilmicin | The therapeutic efficacy of Acetylcholine can be decreased when used in combination with Netilmicin. |